Elite Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ELTP Over the counter 2834 https://www.elitepharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Elite Pharmaceuticals Inc

Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer - May 3rd, 2023 10:00 am
Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product - Apr 20th, 2023 10:00 am
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information - Feb 14th, 2023 10:07 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2023 Financial Results on February 15, 2023 - Feb 8th, 2023 12:00 pm
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study - Feb 7th, 2023 12:00 pm
Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonist - Dec 22nd, 2022 12:00 pm
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information - Nov 15th, 2022 4:30 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022 - Nov 8th, 2022 12:00 pm
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Information - Aug 15th, 2022 8:55 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022 - Aug 11th, 2022 11:00 am
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information - Jun 29th, 2022 8:55 pm
Elite Pharmaceuticals Receives FDA Approval for Generic Sabril(R) - Jun 29th, 2022 11:00 am
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2022 Financial Results on June 30, 2022 - Jun 23rd, 2022 8:30 pm